[1]
|
Grottkau, B.E., Cai, X., Wang, J., Yang, X. and Lin, Y. (2013) Polymeric Nanoparticles for a Drug Delivery System. Current Drug Metabolism, 14, 840-846. http://dx.doi.org/10.2174/138920021131400105
|
[2]
|
He, C., Hu, Y., Yin, L., Tang, C. and Yin, C. (2010) Effects of Particle Size and Surface Charge on Cellular Uptake and Biodistribution of Polymeric Nanoparticles. Biomaterials, 31, 3657-3666. http://dx.doi.org/10.1016/j.biomaterials.2010.01.065
|
[3]
|
Wang, J., Byrne, J.D., Napier, M.E. and DeSimone, J.M. (2011) More Effective Nanomedicines through Particle Design. Small, 7, 1919-1931. http://dx.doi.org/10.1002/smll.201100442
|
[4]
|
Kleber, J.W., Nash, J.F. and Lee, C.C. (1964) Synthetic Polymers as Potential Sustained-Release Coatings. Journal of Pharmaceutical Sciences, 53, 1519-1521. http://dx.doi.org/10.1002/jps.2600531219
|
[5]
|
Singh, R. and Lillard Jr., J.W. (2009) Nanoparticle-Based Targeted Drug Delivery. Experimental and Molecular Pathology, 86, 215-223. http://dx.doi.org/10.1016/j.yexmp.2008.12.004
|
[6]
|
Lamprecht, A., Schafer, U. and Lehr, C.M. (2001) Size-Dependent Bioadhesion of Micro- and Nanoparticulate Carriers to the Inflamed Colonic Mucosa. Pharmaceutical Research, 18, 788-793. http://dx.doi.org/10.1023/A:1011032328064
|
[7]
|
Behrens, I., Pena, A.I., Alonso, M.J. and Kissel, T. (2002) Comparative Uptake Studies of Bioadhesive and Non- Bioadhesive Nanoparticles in Human Intestinal Cell Lines and Rats: The Effect of Mucus on Particle Adsorption and Transport. Pharmaceutical Research, 19, 1185-1193. http://dx.doi.org/10.1023/A:1019854327540
|
[8]
|
Galindo-Rodriguez, S.A., Allemann, E., Fessi, H. and Doelker, E. (2005) Polymeric Nanoparticles for Oral Delivery of Drugs and Vaccines: A Critical Evaluation of in Vivo Studies. Critical ReviewsTM in Therapeutic Drug Carrier Systems, 22, 419-464. http://dx.doi.org/10.1615/CritRevTherDrugCarrierSyst.v22.i5.10
|
[9]
|
Graf, A., McDowell, A. and Rades, T. (2009) Poly(alkylcyanoacrylate) Nanoparticles for Enhanced Delivery of Therapeutics—Is There Real Potential? Expert Opinion on Drug Delivery, 6, 371-387.
|
[10]
|
Vinogradov, S.B.E. and Kabanov, A. (1999) Poly(ethylene glycol)-polyethyleneimine NanoGelTM Particles: Novel Drug Delivery Systems for Antisense Oligonucleotides. Colloids and Surfaces B: Biointerfaces, 16, 291-304.
|
[11]
|
Plapied, L., Duhem, N., Rieux, A.D. and Préat, V. (2011) Fate of Polymeric Nanocarriers for Oral Drug Delivery. Current Opinion in Colloid & Interface, 16, 228-237. http://dx.doi.org/10.1016/j.cocis.2010.12.005
|
[12]
|
Ahlin, P., Kristl, J., Kristl, A. and Vrecer, F. (2002) Investigation of Polymeric Nanoparticles as Carriers of Enalaprilat for Oral Administration. International Journal of Pharmaceutics, 239, 113-120. http://dx.doi.org/10.1016/S0378-5173(02)00076-5
|
[13]
|
Kumari, A., Yadav, S.K. and Yadav, S.C. (2010) Biodegradable Polymeric Nanoparticles Based Drug Delivery Systems. Colloids and Surfaces B: Biointerfaces, 75, 1-18. http://dx.doi.org/10.1016/j.colsurfb.2009.09.001
|
[14]
|
Song, X., Zhao, X., Zhou, Y., Li, S. and Ma, Q. (2010) Pharmacokinetics and Disposition of Various Drug Loaded Biodegradable Poly(Lactide-Co-Glycolide) (PLGA) Nanoparticles. Current Drug Metabolism, 11, 859-869. http://dx.doi.org/10.2174/138920010794479682
|
[15]
|
Chaudhury, A. and Das, S. (2011) Recent Advancement of Chitosan-Based Nanoparticles for Oral Controlled Delivery of Insulin and Other Therapeutic Agents. AAPS PharmSciTech, 12, 10-20. http://dx.doi.org/10.1208/s12249-010-9561-2
|
[16]
|
Liu, Z., Jiao, Y., Wang, Y., Zhou, C. and Zhang, Z. (2008) Polysaccharides-Based Nanoparticles as Drug Delivery Systems. Advanced Drug Delivery Reviews, 60, 1650-1662. http://dx.doi.org/10.1016/j.addr.2008.09.001
|
[17]
|
Hu, C.M., Fang, R.H., Luk, B.T. and Zhang, L. (2013) Polymeric Nanotherapeutics: Clinical Development and Advances in Stealth Functionalization Strategies. Nanoscale, 6, 65-76. http://dx.doi.org/10.1039/C3NR05444F
|
[18]
|
Kamaly, N., Xiao, Z., Valencia, P.M., Radovic-Moreno, A.F. and Farokhzad, O.C. (2012) Targeted Polymeric Therapeutic Nanoparticles: Design, Development and Clinical Translation. Chemical Society Reviews, 41, 2971-3010. http://dx.doi.org/10.1039/c2cs15344k
|
[19]
|
Mundargi, R.C., Babu, V.R., Rangaswamy, V., Patel, P. and Aminabhavi, T.M. (2008) Nano/Micro Technologies for Delivering Macromolecular Therapeutics Using Poly(D,L-Lactide-co-Glycolide) and Its Derivatives. Journal of Controlled Release, 125, 193-209. http://dx.doi.org/10.1016/j.jconrel.2007.09.013
|
[20]
|
Dinarvand, R., Sepehri, N., Manoochehri, S., Rouhani, H. and Atyabi, F. (2011) Polylactide-co-Glycolide Nanoparticles for Controlled Delivery of Anticancer Agents. International Journal of Nanomedicine, 6, 877-895. http://dx.doi.org/10.2147/IJN.S18905
|
[21]
|
Dash, B.C., Rethore, G., Monaghan, M., Fitzgerald, K., Gallagher, W. and Pandit, A. (2010) The Influence of Size and Charge of Chitosan/Polyglutamic Acid Hollow Spheres on Cellular Internalization, Viability and Blood Compatibility. Biomaterials, 31, 8188-8197. http://dx.doi.org/10.1016/j.biomaterials.2010.07.067
|
[22]
|
Conner, S.D. and Schmid, S.L. (2003) Regulated Portals of Entry into the Cell. Nature, 422, 37-44. http://dx.doi.org/10.1038/nature01451
|
[23]
|
Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C. and Zhao, Y. (2011) Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials. Small, 7, 1322-1337. http://dx.doi.org/10.1002/smll.201100001
|
[24]
|
Bhattacharjee, S., Ershov, D., Fytianos, K., van der Gucht, J., Alink, G.M., Rietjens, I.M., et al. (2012) Cytotoxicity and Cellular Uptake of Tri-Block Copolymer Nanoparticles with Different Size and Surface Characteristics. Particle and Fibre Toxicology, 9, 11. http://dx.doi.org/10.1186/1743-8977-9-11
|
[25]
|
Lai, S.K., Hida, K., Man, S.T., Chen, C., Machamer, C., Schroer, T.A., et al. (2007) Privileged Delivery of Polymer Nanoparticles to the Perinuclear Region of Live Cells via a Non-Clathrin, Non-Degradative Pathway. Biomaterials, 28, 2876-2884. http://dx.doi.org/10.1016/j.biomaterials.2007.02.021
|
[26]
|
Dausend, J., Musyanovych, A., Dass, M., Walther, P., Schrezenmeier, H., Landfester, K., et al. (2008) Uptake Mechanism of Oppositely Charged Fluorescent Nanoparticles in HeLa Cells. Macromolecular Bioscience, 8, 1135-1143. http://dx.doi.org/10.1002/mabi.200800123
|
[27]
|
Win, K.Y. and Feng, S.S. (2005) Effects of Particle Size and Surface Coating on Cellular Uptake of Polymeric Nanoparticles for Oral Delivery of Anticancer Drugs. Biomaterials, 26, 2713-2722. http://dx.doi.org/10.1016/j.biomaterials.2004.07.050
|
[28]
|
Foged, C., Brodin, B., Frokjaer, S. and Sundblad, A. (2005) Particle Size and Surface Charge Affect Particle Uptake by Human Dendritic Cells in an in Vitro Model. International Journal of Pharmaceutics, 298, 315-322. http://dx.doi.org/10.1016/j.ijpharm.2005.03.035
|
[29]
|
Mayer, A., Vadon, M., Rinner, B., Novak, A., Wintersteiger, R. and Frohlich, E. (2009) The Role of Nanoparticle Size in Hemocompatibility. Toxicology, 258, 139-147. http://dx.doi.org/10.1016/j.tox.2009.01.015
|
[30]
|
Mura, S., Hillaireau, H., Nicolas, J., Le Droumaguet, B., Gueutin, C., Zanna, S., et al. (2011) Influence of Surface Charge on the Potential Toxicity of PLGA Nanoparticles towards Calu-3 Cells. International Journal of Nanomedicine, 6, 2591-2605.
|
[31]
|
Shen, B.Q., Finkbeiner, W.E., Wine, J.J., Mrsny, R.J. and Widdicombe, J.H. (1994) Calu-3: A Human Airway Epithelial Cell Line That Shows cAMP-Dependent Cl-Secretion. American Journal of Physiology, 266, L493-L501.
|
[32]
|
da Paula, A.C., Ramalho, A.S., Farinha, C.M., Cheung, J., Maurisse, R., Gruenert, D.C., et al. (2005) Characterization of Novel Airway Submucosal Gland Cell Models for Cystic Fibrosis Studies. Cellular Physiology and Biochemistry, 15, 251-262. http://dx.doi.org/10.1159/000087235
|
[33]
|
Arap, W., Haedicke, W., Bernasconi, M., Kain, R., Rajotte, D., Krajewski, S., et al. (2002) Targeting the Prostate for Destruction through a Vascular Address. Proceedings of the National Academy of Sciences of the United States of America, 99, 1527-1531. http://dx.doi.org/10.1073/pnas.241655998
|
[34]
|
Gratton, S.E., Ropp, P.A., Pohlhaus, P.D., Luft, J.C., Madden, V.J., Napier, M.E., et al. (2008) The Effect of Particle Design on Cellular Internalization Pathways. Proceedings of the National Academy of Sciences of the United States of America, 105, 11613-11618. http://dx.doi.org/10.1073/pnas.0801763105
|
[35]
|
Schadlich, A., Caysa, H., Mueller, T., Tenambergen, F., Rose, C., Gopferich, A., et al. (2011) Tumor Accumulation of NIR Fluorescent PEG-PLA Nanoparticles: Impact of Particle Size and Human Xenograft Tumor Model. ACS Nano, 5, 8710-8720. http://dx.doi.org/10.1021/nn2026353
|
[36]
|
Kulkarni, S.A. and Feng, S.S. (2013) Effects of Particle Size and Surface Modification on Cellular Uptake and Biodistribution of Polymeric Nanoparticles for Drug Delivery. Pharmaceutical Research, 30, 2512-2522. http://dx.doi.org/10.1007/s11095-012-0958-3
|
[37]
|
Hillery, A.M. and Florence, F.A. (1996) The Effect of Adsorbed Poloxamer 188 and 407 Surfactants on the Intestinal Uptake of 60-nm Polystyrene Particles after Oral Administration in the Rat. International Journal of Pharmaceutics, 132, 123-130. http://dx.doi.org/10.1016/0378-5173(95)04353-5
|
[38]
|
Faraji, A.H. and Wipf, P. (2009) Nanoparticles in Cellular Drug Delivery. Bioorganic & Medicinal Chemistry, 17, 2950-2962. http://dx.doi.org/10.1016/j.bmc.2009.02.043
|
[39]
|
Alexis, F., Pridgen, E., Molnar, L.K. and Farokhzad, O.C. (2008) Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles. Molecular Pharmaceutics, 5, 505-515. http://dx.doi.org/10.1021/mp800051m
|
[40]
|
Nigavekar, S.S., Sung, L.Y., Llanes, M., El-Jawahri, A., Lawrence, T.S., Becker, C.W., et al. (2004) 3H Dendrimer Nanoparticle Organ/Tumor Distribution. Pharmaceutical Research, 21, 476-483. http://dx.doi.org/10.1023/B:PHAM.0000019302.26097.cc
|
[41]
|
Liu, D., Mori, A. and Huang, L. (1992) Role of Liposome Size and RES Blockade in Controlling Biodistribution and Tumor Uptake of GM1-Containing Liposomes. Biochimica et Biophysica Acta, 1104, 95-101. http://dx.doi.org/10.1016/0005-2736(92)90136-A
|
[42]
|
Akiyama, Y., Mori, T., Katayama, Y. and Niidome, T. (2009) The Effects of PEG Grafting Level and Injection Dose on Gold Nanorod Biodistribution in the Tumor-Bearing Mice. Journal of Controlled Release, 139, 81-84. http://dx.doi.org/10.1016/j.jconrel.2009.06.006
|
[43]
|
Ishiwata, H., Suzuki, N., Ando, S., Kikuchi, H. and Kitagawa, T. (2000) Characteristics and Biodistribution of Cationic Liposomes and Their DNA Complexes. Journal of Controlled Release, 69, 139-148. http://dx.doi.org/10.1016/S0168-3659(00)00293-5
|
[44]
|
Vonarbourg, A., Passirani, C., Saulnier, P., Simard, P., Leroux, J.C. and Benoit, J.P. (2006) Evaluation of Pegylated Lipid Nanocapsules versus Complement System Activation and Macrophage Uptake. Journal of Biomedical Materials Research Part A, 78, 620-628. http://dx.doi.org/10.1002/jbm.a.30711
|
[45]
|
Petros, R.A. and DeSimone, J.M. (2010) Strategies in the Design of Nanoparticles for Therapeutic Applications. Nature Reviews Drug Discovery, 9, 615-627. http://dx.doi.org/10.1038/nrd2591
|
[46]
|
Choi, H.S., Liu, W., Misra, P., Tanaka, E., Zimmer, J.P., Itty Ipe, B., et al. (2007) Renal Clearance of Quantum Dots. Nature Biotechnology, 25, 1165-1170. http://dx.doi.org/10.1038/nbt1340
|
[47]
|
Li, S.D. and Huang, L. (2008) Pharmacokinetics and Biodistribution of Nanoparticles. Molecular Pharmaceutics, 5, 496-504. http://dx.doi.org/10.1021/mp800049w
|
[48]
|
Levchenko, T.S., Rammohan, R., Lukyanov, A.N., Whiteman, K.R. and Torchilin, V.P. (2002) Liposome Clearance in Mice: The Effect of a Separate and Combined Presence of Surface Charge and Polymer Coating. International Journal of Pharmaceutics, 240, 95-102. http://dx.doi.org/10.1016/S0378-5173(02)00129-1
|
[49]
|
Yamamoto, Y., Nagasaki, Y., Kato, Y., Sugiyama, Y. and Kataoka, K. (2001) Long-Circulating Poly(Ethylene Glycol)-Poly(D,L-Lactide) Block Copolymer Micelles with Modulated Surface Charge. Journal of Controlled Release, 77, 27-38. http://dx.doi.org/10.1016/S0168-3659(01)00451-5
|
[50]
|
Ma, Z. and Lim, L.Y. (2003) Uptake of Chitosan and Associated Insulin in Caco-2 Cell Monolayers: A Comparison between Chitosan Molecules and Chitosan Nanoparticles. Pharmaceutical Research, 20, 1812-1819. http://dx.doi.org/10.1023/B:PHAM.0000003379.76417.3e
|
[51]
|
Huang, M., Ma, Z., Khor, E. and Lim, L.Y. (2002) Uptake of FITC-Chitosan Nanoparticles by A549 Cells. Pharmaceutical Research, 19, 1488-1494. http://dx.doi.org/10.1023/A:1020404615898
|
[52]
|
Kim, T.H., Park, I.K., Nah, J.W., Choi, Y.J. and Cho, C.S. (2004) Galactosylated Chitosan/DNA Nanoparticles Prepared Using Water-Soluble Chitosan as a Gene Carrier. Biomaterials, 25, 3783-3792. http://dx.doi.org/10.1016/j.biomaterials.2003.10.063
|
[53]
|
Han, H.D., Mangala, L.S., Lee, J.W., Shahzad, M.M., Kim, H.S., Shen, D., et al. (2010) Targeted Gene Silencing Using RGD-Labeled Chitosan Nanoparticles. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 16, 3910-3922.
|
[54]
|
Aktas, Y., Yemisci, M., Andrieux, K., Gursoy, R.N., Alonso, M.J., Fernandez-Megia, E., et al. (2005) Development and Brain Delivery of Chitosan-PEG Nanoparticles Functionalized with the Monoclonal Antibody OX26. Bioconjugate Chemistry, 16, 1503-1511. http://dx.doi.org/10.1021/bc050217o
|
[55]
|
Balthasar, S., Michaelis, K., Dinauer, N., von Briesen, H., Kreuter, J. and Langer, K. (2005) Preparation and Characterisation of Antibody Modified Gelatin Nanoparticles as Drug Carrier System for Uptake in Lymphocytes. Biomaterials, 26, 2723-2732. http://dx.doi.org/10.1016/j.biomaterials.2004.07.047
|
[56]
|
Wang, X., Li, J., Wang, Y., Cho, K.J., Kim, G., Gjyrezi, A., et al. (2009) HFT-T, a Targeting Nanoparticle, Enhances Specific Delivery of Paclitaxel to Folate Receptor-Positive Tumors. ACS Nano, 3, 3165-3174. http://dx.doi.org/10.1021/nn900649v
|
[57]
|
Choi, K.Y., Chung, H., Min, K.H., Yoon, H.Y., Kim, K., Park, J.H., et al. (2010) Self-Assembled Hyaluronic Acid Nanoparticles for Active Tumor Targeting. Biomaterials, 31, 106-114. http://dx.doi.org/10.1016/j.biomaterials.2009.09.030
|
[58]
|
Cho, H.J., Yoon, H.Y., Koo, H., Ko, S.H., Shim, J.S., Lee, J.H., et al. (2011) Self-Assembled Nanoparticles Based on Hyaluronic Acid-Ceramide (HA-CE) and Pluronic(R) for Tumor-Targeted Delivery of Docetaxel. Biomaterials, 32, 7181-7190. http://dx.doi.org/10.1016/j.biomaterials.2011.06.028
|
[59]
|
Nam, H.Y., Kwon, S.M., Chung, H., Lee, S.Y., Kwon, S.H., Jeon, H., et al. (2009) Cellular Uptake Mechanism and Intracellular Fate of Hydrophobically Modified Glycol Chitosan Nanoparticles. Journal of Controlled Release, 135, 259-267.
|
[60]
|
Chung, T.H., Wu, S.H., Yao, M., Lu, C.W., Lin, Y.S., Hung, Y., et al. (2007) The Effect of Surface Charge on the Uptake and Biological Function of Mesoporous Silica Nanoparticles in 3T3-L1 Cells and Human Mesenchymal Stem Cells. Biomaterials, 28, 2959-2966. http://dx.doi.org/10.1016/j.biomaterials.2007.03.006
|
[61]
|
Ko, J., Park, K., Kim, Y.S., Kim, M.S., Han, J.K., Kim, K., et al. (2007) Tumoral Acidic Extracellular pH Targeting of pH-Responsive MPEG-Poly(Beta-Amino Ester) Block Copolymer Micelles for Cancer Therapy. Journal of Controlled Release, 123, 109-115.
|
[62]
|
Park, J.S., Han, T.H., Lee, K.Y., Han, S.S., Hwang, J.J., Moon, D.H., et al. (2006) N-Acetyl Histidine-Conjugated Glycol Chitosan Self-Assembled Nanoparticles for Intracytoplasmic Delivery of Drugs: Endocytosis, Exocytosis and Drug Release. Journal of Controlled Release, 115, 37-45.
|
[63]
|
Wang, Y., Gao, S., Ye, W.H., Yoon, H.S. and Yang, Y.Y. (2006) Co-Delivery of Drugs and DNA from Cationic Core-Shell Nanoparticles Self-Assembled from a Biodegradable Copolymer. Nature Materials, 5, 791-796. http://dx.doi.org/10.1038/nmat1737
|
[64]
|
Chawla, J.S. and Amiji, M.M. (2002) Biodegradable Poly(Epsilon-Caprolactone) Nanoparticles for Tumor-Targeted Delivery of taMoxifen. International Journal of Pharmaceutics, 249, 127-138. http://dx.doi.org/10.1016/S0378-5173(02)00483-0
|
[65]
|
Chawla, J.S. and Amiji, M.M. (2003) Cellular Uptake and Concentrations of Tamoxifen upon Administration in Poly(Epsilon-Caprolactone) Nanoparticles. AAPS PharmSci, 5, 28-34. http://dx.doi.org/10.1208/ps050103
|
[66]
|
Cade, D., Ramus, E., Rinaudo, M., Auzely-Velty, R., Delair, T. and Hamaide, T. (2004) Tailoring of Bioresorbable Polymers for Elaboration of Sugar-Functionalized Nanoparticles. Biomacromolecules, 5, 922-927. http://dx.doi.org/10.1021/bm034504b
|
[67]
|
Wang, J., Tian, S., Petros, R.A., Napier, M.E. and Desimone, J.M. (2010) The Complex Role of Multivalency in Nanoparticles Targeting the Transferrin Receptor for Cancer Therapies. Journal of the American Chemical Society, 132, 11306-11313. http://dx.doi.org/10.1021/ja1043177
|
[68]
|
Lee, H., Fonge, H., Hoang, B., Reilly, R.M. and Allen, C. (2010) The Effects of Particle Size and Molecular Targeting on the Intratumoral and Subcellular Distribution of Polymeric Nanoparticles. Molecular Pharmaceutics, 7, 1195-1208. http://dx.doi.org/10.1021/mp100038h
|
[69]
|
Xin, H., Jiang, X., Gu, J., Sha, X., Chen, L., Law, K., et al. (2011) Angiopep-Conjugated Poly(Ethylene Glycol)-co-Poly(Epsilon-Caprolactone) Nanoparticles as Dual-Targeting Drug Delivery System for Brain Glioma. Biomaterials, 32, 4293-4305. http://dx.doi.org/10.1016/j.biomaterials.2011.02.044
|
[70]
|
Kim, H.R., Gil, S., Andrieux, K., Nicolas, V., Appel, M., Chacun, H., et al. (2007) Low-Density Lipoprotein Receptor-Mediated Endocytosis of PEGylated Nanoparticles in Rat Brain Endothelial Cells. Cellular and Molecular Life Sciences: CMLS, 64, 356-364. http://dx.doi.org/10.1007/s00018-007-6390-x
|
[71]
|
Harush-Frenkel, O., Debotton, N., Benita, S. and Altschuler, Y. (2007) Targeting of Nanoparticles to the Clathrin-Mediated Endocytic Pathway. Biochemical and Biophysical Research Communications, 353, 26-32. http://dx.doi.org/10.1016/j.bbrc.2006.11.135
|
[72]
|
Lu, W., Tan, Y.Z., Hu, K.L. and Jiang, X.G. (2005) Cationic Albumin Conjugated Pegylated Nanoparticle with Its Transcytosis Ability and Little Toxicity Against Blood-Brain Barrier. International Journal of Pharmaceutics, 295, 247-260. http://dx.doi.org/10.1016/j.ijpharm.2005.01.043
|
[73]
|
Harush-Frenkel, O., Rozentur, E., Benita, S. and Altschuler, Y. (2008) Surface Charge of Nanoparticles Determines Their Endocytic and Transcytotic Pathway in Polarized MDCK Cells. Biomacromolecules, 9, 435-443. http://dx.doi.org/10.1021/bm700535p
|
[74]
|
Aryal, S., Hu, C.M. and Zhang, L. (2010) Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery. ACS Nano, 4, 251-258. http://dx.doi.org/10.1021/nn9014032
|
[75]
|
Danhier, F., Lecouturier, N., Vroman, B., Jerome, C., Marchand-Brynaert, J., Feron, O., et al. (2009) Paclitaxel-Loaded PEGylated PLGA-Based Nanoparticles: In Vitro and In Vivo Evaluation. Journal of Controlled Release, 133, 11-17.
|
[76]
|
Mao, S., Germershaus, O., Fischer, D., Linn, T., Schnepf, R. and Kissel, T. (2005) Uptake and Transport of PEG- Graft-Trimethyl-Chitosan Copolymer-Insulin Nanocomplexes by Epithelial Cells. Pharmaceutical Research, 22, 2058- 2068. http://dx.doi.org/10.1007/s11095-005-8175-y
|
[77]
|
Nukolova, N.V., Oberoi, H.S., Cohen, S.M., Kabanov, A.V. and Bronich, T.K. (2011) Folate-Decorated Nanogels for Targeted Therapy of Ovarian Cancer. Biomaterials, 32, 5417-5426. http://dx.doi.org/10.1016/j.biomaterials.2011.04.006
|
[78]
|
Cho, C.S., Cho, K.Y., Park, I.K., Kim, S.H., Sasagawa, T., Uchiyama, M., et al. (2001) Receptor-Mediated Delivery of All Trans-Retinoic Acid to Hepatocyte Using Poly(L-Lactic Acid) Nanoparticles Coated with Galactose-Carrying Polystyrene. Journal of Controlled Release, 77, 7-15.
|
[79]
|
Banquy, X., Leclair, G., Rabanel, J.M., Argaw, A., Bouchard, J.F., Hildgen, P., et al. (2008) Selectins Ligand Decorated Drug Carriers for Activated Endothelial Cell Targeting. Bioconjugate Chemistry, 19, 2030-2039. http://dx.doi.org/10.1021/bc800257m
|
[80]
|
Nasongkla, N., Bey, E., Ren, J., Ai, H., Khemtong, C., Guthi, J.S., et al. (2006) Multifunctional Polymeric Micelles as Cancer-Targeted, MRI-Ultrasensitive Drug Delivery Systems. Nano Letters, 6, 2427-2430. http://dx.doi.org/10.1021/nl061412u
|
[81]
|
Prabha, S. and Labhasetwar, V. (2004) Critical Determinants in PLGA/PLA Nanoparticle-Mediated Gene Expression. Pharmaceutical Research, 21, 354-364. http://dx.doi.org/10.1023/B:PHAM.0000016250.56402.99
|
[82]
|
Musumeci, T., Ventura, C.A., Giannone, I., Ruozi, B., Montenegro, L., Pignatello, R., et al. (2006) PLA/PLGA Nanoparticles for Sustained Release of Docetaxel. International Journal of Pharmaceutics, 325, 172-179. http://dx.doi.org/10.1016/j.ijpharm.2006.06.023
|
[83]
|
Prabha, S., Zhou, W.Z., Panyam, J. and Labhasetwar, V. (2002) Size-Dependency of Nanoparticle-Mediated Gene Transfection: Studies with Fractionated Nanoparticles. International Journal of Pharmaceutics, 244, 105-115. http://dx.doi.org/10.1016/S0378-5173(02)00315-0
|
[84]
|
Sahoo, S.K., Panyam, J., Prabha, S. and Labhasetwar, V. (2002) Residual Polyvinyl Alcohol Associated with Poly (D,L-Lactide-co-Glycolide) Nanoparticles Affects Their Physical Properties and Cellular Uptake. Journal of Controlled Release, 82, 105-114.
|
[85]
|
Sahoo, S.K. and Labhasetwar, V. (2005) Enhanced Antiproliferative Activity of Transferrin-Conjugated Paclitaxel-Loaded Nanoparticles Is Mediated via Sustained Intracellular Drug Retention. Molecular Pharmaceutics, 2, 373-383. http://dx.doi.org/10.1021/mp050032z
|
[86]
|
Obermajer, N., Kocbek, P., Repnik, U., Kuznik, A., Cegnar, M., Kristl, J., et al. (2007) Immunonanoparticles—An Effective Tool to Impair Harmful Proteolysis in Invasive Breast Tumor Cells. The FEBS Journal, 274, 4416-4427. http://dx.doi.org/10.1111/j.1742-4658.2007.05971.x
|
[87]
|
Davda, J. and Labhasetwar, V. (2002) Characterization of Nanoparticle Uptake by Endothelial Cells. International Journal of Pharmaceutics, 233, 51-59. http://dx.doi.org/10.1016/S0378-5173(01)00923-1
|
[88]
|
Mo, Y. and Lim, L.Y. (2005) Preparation and in Vitro Anticancer Activity of Wheat Germ Agglutinin (WGA)-Conjugated PLGA Nanoparticles Loaded with Paclitaxel and Isopropyl Myristate. Journal of Controlled Release, 107, 30-42.
|
[89]
|
Mo, Y. and Lim, L.Y. (2005) Paclitaxel-Loaded PLGA Nanoparticles: Potentiation of Anticancer Activity by Surface Conjugation with Wheat Germ Agglutinin. Journal of Controlled Release, 108, 244-262.
|
[90]
|
Mo, Y. and Lim, L.Y. (2004) Mechanistic Study of the Uptake of Wheat Germ Agglutinin-Conjugated PLGA Nanoparticles by A549 Cells. Journal of Pharmaceutical Sciences, 93, 20-28. http://dx.doi.org/10.1002/jps.10507
|
[91]
|
McCarron, P.A., Marouf, W.M., Quinn, D.J., Fay, F., Burden, R.E., Olwill, S.A., et al. (2008) Antibody Targeting of Camptothecin-Loaded PLGA Nanoparticles to Tumor Cells. Bioconjugate Chemistry, 19, 1561-1569. http://dx.doi.org/10.1021/bc800057g
|
[92]
|
Tosi, G., Fano, R.A., Bondioli, L., Badiali, L., Benassi, R., Rivasi, F., et al. (2011) Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier. Nanomedicine, 6, 423-436. http://dx.doi.org/10.2217/nnm.11.11
|
[93]
|
Fonseca, C., Simoes, S. and Gaspar, R. (2002) Paclitaxel-Loaded PLGA Nanoparticles: Preparation, Physicochemical Characterization and in Vitro Anti-Tumoral Activity. Journal of Controlled Release, 83, 273-286.
|
[94]
|
Xie, J. and Wang, C.H. (2005) Self-Assembled Biodegradable Nanoparticles Developed by Direct Dialysis for the Delivery of Paclitaxel. Pharmaceutical Research, 22, 2079-2090. http://dx.doi.org/10.1007/s11095-005-7782-y
|
[95]
|
Esmaeili, F., Dinarvand, R., Ghahremani, M.H., Ostad, S.N., Esmaily, H. and Atyabi, F. (2010) Cellular Cytotoxicity and In-Vivo Biodistribution of Docetaxel Poly(Lactide-co-Glycolide) Nanoparticles. Anti-Cancer Drugs, 21, 43-52. http://dx.doi.org/10.1097/CAD.0b013e328331f934
|
[96]
|
Betancourt, T., Brown, B. and Brannon-Peppas, L. (2007) Doxorubicin-Loaded PLGA Nanoparticles by Nanoprecipitation: Preparation, Characterization and in Vitro Evaluation. Nanomedicine, 2, 219-232. http://dx.doi.org/10.2217/17435889.2.2.219
|
[97]
|
Manchanda, R., Fernandez-Fernandez, A., Nagesetti, A. and McGoron, A.J. (2010) Preparation and Characterization of a Polymeric (PLGA) Nanoparticulate Drug Delivery System with Simultaneous Incorporation of Chemotherapeutic and Thermo-Optical Agents. Colloids and Surfaces B: Biointerfaces, 75, 260-267. http://dx.doi.org/10.1016/j.colsurfb.2009.08.043
|
[98]
|
Yallapu, M.M., Gupta, B.K., Jaggi, M. and Chauhan, S.C. (2010) Fabrication of Curcumin Encapsulated PLGA Nanoparticles for Improved Therapeutic Effects in Metastatic Cancer Cells. Journal of Colloid and Interface Science, 351, 19-29. http://dx.doi.org/10.1016/j.jcis.2010.05.022
|
[99]
|
Yan, F., Zhang, C., Zheng, Y., Mei, L., Tang, L., Song, C., et al. (2010) The Effect of Poloxamer 188 on Nanoparticle Morphology, Size, Cancer Cell Uptake, and Cytotoxicity. Nanomedicine, 6, 170-178. http://dx.doi.org/10.1016/j.nano.2009.05.004
|
[100]
|
Song, X.R., Cai, Z., Zheng, Y., He, G., Cui, F.Y., Gong, D.Q., et al. (2009) Reversion of Multidrug Resistance by Co-Encapsulation of Vincristine and Verapamil in PLGA Nanoparticles. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences, 37, 300-305.
|
[101]
|
Zeisser-Labouebe, M., Lange, N., Gurny, R. and Delie, F. (2006) Hypericin-Loaded Nanoparticles for the Photodynamic Treatment of Ovarian Cancer. International Journal of Pharmaceutics, 326, 174-181. http://dx.doi.org/10.1016/j.ijpharm.2006.07.012
|
[102]
|
Shah, N., Chaudhari, K., Dantuluri, P., Murthy, R.S. and Das, S. (2009) Paclitaxel-Loaded PLGA Nanoparticles Surface Modified with Transferrin and Pluronic((R))P85, an in Vitro Cell Line and in Vivo Biodistribution Studies on Rat Model. Journal of Drug Targeting, 17, 533-542. http://dx.doi.org/10.1080/10611860903046628
|
[103]
|
Win, K.Y. and Feng, S.S. (2006) In Vitro and in Vivo Studies on Vitamin E TPGS-Emulsified Poly(D,L-Lactic-co-Glycolic Acid) Nanoparticles for Paclitaxel Formulation. Biomaterials, 27, 2285-2291. http://dx.doi.org/10.1016/j.biomaterials.2005.11.008
|
[104]
|
Dong, Y. and Feng, S.S. (2007) Poly(D,L-Lactide-co-Glycolide) (PLGA) Nanoparticles Prepared by High Pressure Homogenization for Paclitaxel Chemotherapy. International Journal of Pharmaceutics, 342, 208-214. http://dx.doi.org/10.1016/j.ijpharm.2007.04.031
|
[105]
|
Bondioli, L., Costantino, L., Ballestrazzi, A., Lucchesi, D., Boraschi, D., Pellati, F., et al. (2010) PLGA Nanoparticles Surface Decorated with the Sialic Acid, N-Acetylneuraminic Acid. Biomaterials, 31, 3395-3403. http://dx.doi.org/10.1016/j.biomaterials.2010.01.049
|
[106]
|
Zheng, Y., Yu, B., Weecharangsan, W., Piao, L., Darby, M., Mao, Y., et al. (2010) Transferrin-Conjugated Lipid-Coated PLGA Nanoparticles for Targeted Delivery of Aromatase Inhibitor 7alpha-APTADD to Breast Cancer Cells. International Journal of Pharmaceutics, 390, 234-241. http://dx.doi.org/10.1016/j.ijpharm.2010.02.008
|
[107]
|
Kou, G., Gao, J., Wang, H., Chen, H., Li, B., Zhang, D., et al. (2007) Preparation and Characterization of Paclitaxel-Loaded PLGA Nanoparticles Coated with Cationic SM5-1 Single-Chain Antibody. Journal of Biochemistry and Molecular Biology, 40, 731-739. http://dx.doi.org/10.5483/BMBRep.2007.40.5.731
|
[108]
|
Kocbek, P., Obermajer, N., Cegnar, M., Kos, J. and Kristl, J. (2007) Targeting Cancer Cells Using PLGA Nanoparticles Surface Modified with Monoclonal Antibody. Journal of Controlled Release, 120, 18-26.
|
[109]
|
Acharya, S., Dilnawaz, F. and Sahoo, S.K. (2009) Targeted Epidermal Growth Factor Receptor Nanoparticle Bioconjugates for Breast Cancer Therapy. Biomaterials, 30, 5737-5750. http://dx.doi.org/10.1016/j.biomaterials.2009.07.008
|
[110]
|
Sun, B., Ranganathan, B. and Feng, S.S. (2008) Multifunctional Poly(D,L-Lactide-co-Glycolide)/Montmorillonite (PLGA/MMT) Nanoparticles Decorated by Trastuzumab for Targeted Chemotherapy of Breast Cancer. Biomaterials, 29, 475-486. http://dx.doi.org/10.1016/j.biomaterials.2007.09.038
|
[111]
|
Gao, J., Kou, G., Wang, H., Chen, H., Li, B., Lu, Y., et al. (2009) PE38KDEL-Loaded Anti-HER2 Nanoparticles Inhibit Breast Tumor Progression with Reduced Toxicity and Immunogenicity. Breast Cancer Research and Treatment, 115, 29-41. http://dx.doi.org/10.1007/s10549-008-0043-0
|
[112]
|
Bicho, A., Peca, I.N., Roque, A.C. and Cardoso, M.M. (2010) Anti-CD8 Conjugated Nanoparticles to Target Mammalian Cells Expressing CD8. International Journal of Pharmaceutics, 399, 80-86. http://dx.doi.org/10.1016/j.ijpharm.2010.08.005
|
[113]
|
Cruz, L.J., Tacken, P.J., Fokkink, R., Joosten, B., Stuart, M.C., Albericio, F., et al. (2010) Targeted PLGA Nano- but Not Microparticles Specifically Deliver Antigen to Human Dendritic Cells via DC-SIGN in Vitro. Journal of Controlled Release, 144, 118-126.
|
[114]
|
Alshamsan, A., Haddadi, A., Hamdy, S., Samuel, J., El-Kadi, A.O., Uludag, H., et al. (2010) STAT3 Silencing in Dendritic Cells by siRNA Polyplexes Encapsulated in PLGA Nanoparticles for the Modulation of Anticancer Immune Response. Molecular Pharmaceutics, 7, 1643-1654. http://dx.doi.org/10.1021/mp100067u
|
[115]
|
Ghotbi, Z., Haddadi, A., Hamdy, S., Hung, R.W., Samuel, J. and Lavasanifar, A. (2011) Active Targeting of Dendritic Cells with Mannan-Decorated PLGA Nanoparticles. Journal of Drug Targeting, 19, 281-292. http://dx.doi.org/10.3109/1061186X.2010.499463
|
[116]
|
Haddadi, A., Elamanchili, P., Lavasanifar, A., Das, S., Shapiro, J. and Samuel, J. (2008) Delivery of Rapamycin by PLGA Nanoparticles Enhances Its Suppressive Activity on Dendritic Cells. Journal of Biomedical Materials Research Part A, 84, 885-898. http://dx.doi.org/10.1002/jbm.a.31373
|
[117]
|
Panyam, J., Williams, D., Dash, A., Leslie-Pelecky, D. and Labhasetwar, V. (2004) Solid-State Solubility Influences Encapsulation and Release of Hydrophobic Drugs from PLGA/PLA Nanoparticles. Journal of Pharmaceutical Sciences, 93, 1804-1814. http://dx.doi.org/10.1002/jps.20094
|
[118]
|
Panyam, J. and Labhasetwar, V. (2003) Dynamics of Endocytosis and Exocytosis of Poly(D,L-Lactide-co-Glycolide) Nanoparticles in Vascular Smooth Muscle Cells. Pharmaceutical Research, 20, 212-20. http://dx.doi.org/10.1023/A:1022219003551
|
[119]
|
Panyam, J., Zhou, W.Z., Prabha, S., Sahoo, S.K. and Labhasetwar, V. (2002) Rapid Endo-Lysosomal Escape of Poly- (DL-Lactide-co-Glycolide) Nanoparticles: Implications for Drug and Gene Delivery. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology, 16, 1217-1226.
|
[120]
|
Vasir, J.K. and Labhasetwar, V. (2007)Biodegradable nanoparticles for cytosolic delivery of therapeutics. Advanced drug delivery reviews, 5, 718-728. http://dx.doi.org/10.1016/j.addr.2007.06.003
|
[121]
|
Zhang, N., Chittasupho, C., Duangrat, C., Siahaan, T.J. and Berkland, C. (2008) PLGA Nanoparticle-Peptide Conjugate Effectively Targets Intercellular Cell-Adhesion Molecule-1. Bioconjugate Chemistry, 19, 145-152. http://dx.doi.org/10.1021/bc700227z
|
[122]
|
Townsend, S.A., Evrony, G.D., Gu, F.X., Schulz, M.P., Brown Jr., R.H. and Langer, R. (2007) Tetanus Toxin C Fragment-Conjugated Nanoparticles for Targeted Drug Delivery to Neurons. Biomaterials, 28, 5176-51784. http://dx.doi.org/10.1016/j.biomaterials.2007.08.011
|
[123]
|
Cheng, J., Teply, B.A., Sherifi, I., Sung, J., Luther, G., Gu, F.X., et al. (2007) Formulation of Functionalized PLGA-PEG Nanoparticles for in Vivo Targeted Drug Delivery. Biomaterials, 28, 869-876. http://dx.doi.org/10.1016/j.biomaterials.2006.09.047
|
[124]
|
Dhar, S., Gu, F.X., Langer, R., Farokhzad, O.C. and Lippard, S.J. (2008) Targeted Delivery of Cisplatin to Prostate Cancer Cells by Aptamer Functionalized Pt(IV) Prodrug-PLGA-PEG Nanoparticles. Proceedings of the National Academy of Sciences of the United States of America, 105, 17356-17361. http://dx.doi.org/10.1073/pnas.0809154105
|
[125]
|
Li, J., Feng, L., Fan, L., Zha, Y., Guo, L., Zhang, Q., et al. (2011) Targeting the Brain with PEG-PLGA Nanoparticles Modified with Phage-Displayed Peptides. Biomaterials, 32, 4943-4950. http://dx.doi.org/10.1016/j.biomaterials.2011.03.031
|
[126]
|
Gryparis, E.C., Hatziapostolou, M., Papadimitriou, E. and Avgoustakis, K. (2007) Anticancer Activity of Cisplatin-Loaded PLGA-mPEG Nanoparticles on LNCaP Prostate Cancer Cells. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV, 67, 1-8.
|
[127]
|
Wang, Z., Chui, W.K. and Ho, P.C. (2009) Design of a Multifunctional PLGA Nanoparticulate Drug Delivery System: Evaluation of Its Physicochemical Properties and Anticancer Activity to Malignant Cancer Cells. Pharmaceutical Research, 26, 1162-1171. http://dx.doi.org/10.1007/s11095-009-9837-y
|
[128]
|
Danhier, F., Vroman, B., Lecouturier, N., Crokart, N., Pourcelle, V., Freichels, H., et al. (2009) Targeting of Tumor Endothelium by RGD-Grafted PLGA-Nanoparticles Loaded with Paclitaxel. Journal of Controlled Release, 140, 166-173.
|
[129]
|
Patil, Y., Sadhukha, T., Ma, L. and Panyam, J. (2009) Nanoparticle-Mediated Simultaneous and Targeted Delivery of Paclitaxel and Tariquidar Overcomes Tumor Drug Resistance. Journal of Controlled Release, 136, 21-29.
|
[130]
|
Farokhzad, O.C., Cheng, J., Teply, B.A., Sherifi, I., Jon, S., Kantoff, P.W., et al. (2006) Targeted Nanoparticle-Ap-tamer Bioconjugates for Cancer Chemotherapy in Vivo. Proceedings of the National Academy of Sciences of the United States of America, 103, 6315-6320. http://dx.doi.org/10.1073/pnas.0601755103
|
[131]
|
Esmaeili, F., Ghahremani, M.H., Ostad, S.N., Atyabi, F., Seyedabadi, M., Malekshahi, M.R., et al. (2008) Folate-Receptor-Targeted Delivery of Docetaxel Nanoparticles Prepared by PLGA-PEG-Folate Conjugate. Journal of Drug Targeting, 16, 415-423. http://dx.doi.org/10.1080/10611860802088630
|
[132]
|
Gu, F., Zhang, L., Teply, B.A., Mann, N., Wang, A., Radovic-Moreno, A.F., et al. (2008) Precise Engineering of Targeted Nanoparticles by Using Self-Assembled Biointegrated Block Copolymers. Proceedings of the National Academy of Sciences of the United States of America, 105, 2586-2591. http://dx.doi.org/10.1073/pnas.0711714105
|
[133]
|
Bivas-Benita, M., Romeijn, S., Junginger, H.E. and Borchard, G. (2004) PLGA-PEI Nanoparticles for Gene Delivery to Pulmonary Epithelium. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik eV, 58, 1-6.
|
[134]
|
Patil, Y.B., Swaminathan, S.K., Sadhukha, T., Ma, L. and Panyam, J. (2010) The Use of Nanoparticle-Mediated Targeted Gene Silencing and Drug Delivery to Overcome Tumor Drug Resistance. Biomaterials, 31, 358-65. http://dx.doi.org/10.1016/j.biomaterials.2009.09.048
|
[135]
|
Chen, H., Zheng, Y., Tian, G., Tian, Y., Zeng, X., Liu, G., et al. (2011) Oral Delivery of DMAB-Modified Docetaxel-Loaded PLGA-TPGS Nanoparticles for Cancer Chemotherapy. Nanoscale Research Letters, 6, 4.
|
[136]
|
Zhang, Z.P., Lee, S.H. and Feng, S.-S. (2007) Folate-Decorated Poly(Lactide-co-Glycolide)-Vitamin E TPGS Nano-particles for Targeted Drug Delivery. Biomaterials, 28, 1889-1899. http://dx.doi.org/10.1016/j.biomaterials.2006.12.018
|
[137]
|
Ma, Y., Zheng, Y., Liu, K., Tian, G., Tian, Y., Xu, L., et al. (2010) Nanoparticles of Poly(Lactide-Co-Glycolide)-d-a-Tocopheryl Polyethylene Glycol 1000 Succinate Random Copolymer for Cancer Treatment. Nanoscale Research Letters, 5, 1161-1169. http://dx.doi.org/10.1007/s11671-010-9620-3
|
[138]
|
Iwasaki, Y., Maie, H. and Akiyoshi, K. (2007) Cell-Specific Delivery of Polymeric Nanoparticles to Carbohydrate-Tagging Cells. Biomacromolecules, 8, 3162-3168. http://dx.doi.org/10.1021/bm700606z
|
[139]
|
Shenoy, D., Little, S., Langer, R. and Amiji, M. (2005) Poly(Ethylene Oxide)-Modified Poly(Beta-Amino Ester) Nanoparticles as a pH-Sensitive System for Tumor-Targeted Delivery of Hydrophobic Drugs: Part 2. In Vivo Distribution and Tumor Localization Studies. Pharmaceutical Research, 22, 2107-2114. http://dx.doi.org/10.1007/s11095-005-8343-0
|
[140]
|
Green, J.J., Chiu, E., Leshchiner, E.S., Shi, J., Langer, R. and Anderson, D.G. (2007) Electrostatic Ligand Coatings of Nanoparticles Enable Ligand-Specific Gene Delivery to Human Primary Cells. Nano Letters, 7, 874-879. http://dx.doi.org/10.1021/nl062395b
|
[141]
|
Ding, H., Inoue, S., Ljubimov, A.V., Patil, R., Portilla-Arias, J., Hu, J., et al. (2010) Inhibition of Brain Tumor Growth by Intravenous Poly(β-L-Malic Acid) Nanobioconjugate with pH-Dependent Drug Release. Proceedings of the National Academy of Sciences of the United States of America, 107, 18143-18148. http://dx.doi.org/10.1073/pnas.1003919107
|
[142]
|
Inoue, S., Ding, H., Portilla-Arias, J., Hu, J., Konda, B., Fujita, M., et al. (2011) Polymalic Provides Efficient Systemic Breast Cancer Treatment by Inhibiting Both HER2/Neu Receptor Synthesis and Activity. Cancer Research, 71, 1454-1464. http://dx.doi.org/10.1158/0008-5472.CAN-10-3093
|
[143]
|
Liang, H.F., Chen, S.C., Chen, M.C., Lee, P.W., Chen, C.T. and Sung, H.W. (2006) Paclitaxel-Loaded Poly(Gamma-Glutamic Acid)-Poly(Lactide) Nanoparticles as a Targeted Drug Delivery System against Cultured HepG2 Cells. Bioconjugate Chemistry, 17, 291-299. http://dx.doi.org/10.1021/bc0502107
|
[144]
|
Lai, S.K., Hida, K., Chen, C. and Hanes, J. (2008) Characterization of the Intracellular Dynamics of a Non-Degradative Pathway Accessed by Polymer Nanoparticles. Journal of Controlled Release, 125, 107-111.
|
[145]
|
Bellocq, N.C., Pun, S.H., Jensen, G.S. and Davis, M.E. (2003) Transferrin-Containing, Cyclodextrin Polymer-Based Particles for Tumor-Targeted Gene Delivery. Bioconjugate Chemistry, 14, 1122-1132. http://dx.doi.org/10.1021/bc034125f
|